Skip to main content
. Author manuscript; available in PMC: 2013 Sep 11.
Published in final edited form as: Circulation. 2012 Sep 11;126(11 Suppl 1):S54–S64. doi: 10.1161/CIRCULATIONAHA.112.092627

Figure 4.

Figure 4

Example of changes in the size of an infarct from baseline (before CSC infusion) to 4 and 12 months after CSC infusion. The numbers (in white) denote the infarct size (in g) in the slice shown; CSC=cardiac stem cell, FWHM=“full-width half-maximum” method, which uses all areas with >50% of the maximal signal intensity to define the infarcted myocardium. Note the decrease in gadolinium enhancement in the inferolateral wall at 4 months after CSCs, which persisted at 12 months.